Literature DB >> 9251922

Factors determining pubertal growth and final height in growth hormone treatment of idiopathic growth hormone deficiency. Analysis of 195 Patients of the Kabi Pharmacia International Growth Study.

M B Ranke1, D A Price, K Albertsson-Wikland, M Maes, A Lindberg.   

Abstract

A total of 195 children (117 males and 78 females) with idiopathic growth hormone deficiency (IGHD) treated with growth hormone (GH) for at least 1 year before puberty onset and who had completed treatment to adult height, were selected from the KIGS database for study of growth during puberty. Spontaneous and induced puberty started at 13.8 and 14.9 years in boys and at 12.9 and 13.7 years in girls, respectively. Duration of GH treatment and height gained prepubertally were greater when puberty was induced; prepubertal catch up growth (expressed as a percentage of the difference between target height and height at start of GH) was greater when puberty was induced in boys (59% induced vs. 45% spontaneous, p < 0.001), and in girls (72% induced vs. 53.9% spontaneous, p < 0.01). Final height was attained at 17.8 and 19.2 years in boys and at 16.0 and 17.0 years in girls following spontaneous and induced puberty, respectively. Final heights were greater after induced puberty compared with spontaneous puberty in boys (171.3 vs. 166.0 cm, p < 0.001) and in girls (157.0 vs. 155.0 cm, n.s.). Target height was also significantly greater in boys with spontaneous puberty (172.2 cm vs. induced = 174.2 cm) as compared to girls (spontaneous = 158 cm vs. induced = 160 cm). Duration of pubertal growth was longer in boys compared to girls (3.6 vs. 3.0 years, p < 0.001) and was negatively correlated with age, height, and distance from target height at onset of puberty, but was not correlated with the dose of GH. Catch-up growth during puberty (expressed as a percentage of the difference between target height and height at puberty onset) after induced and spontaneous puberty was 87.9% and 80.5% (not significant) in boys and 66.4% and 75.5% (not significant in girls. Total pubertal growth (TPG) (cm) was inversely correlated with prepubertal growth by simple linear regression. Multiple linear regression analysis indicated 5 independent predictors of TPG accounting for 78% of the variability, namely sex (boys grew more), distance of target height from height at onset of puberty (+), dose of GH at onset of puberty (+), age at onset of puberty (-), and age at end of growth (+).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9251922     DOI: 10.1159/000185487

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  10 in total

1.  Growth hormone in growth hormone deficiency.

Authors:  Paul Saenger
Journal:  BMJ       Date:  2002-07-13

Review 2.  Growth hormone therapy.

Authors:  Anurag Bajpai; P Sn Menon
Journal:  Indian J Pediatr       Date:  2005-02       Impact factor: 1.967

Review 3.  The use of somatropin (recombinant growth hormone) in children of short stature.

Authors:  Ameeta Mehta; Peter C Hindmarsh
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

4.  Outcome of growth hormone therapy in children with growth hormone deficiency showing an inadequate response to growth hormone-releasing hormone.

Authors:  P Saenger; O H Pescovitz; B B Bercu; F T Murray; H Landy; J Brentzel; L O'Dea; B Hanson; C Howard; E O Reiter
Journal:  Endocrine       Date:  2001-06       Impact factor: 3.633

5.  Early detection of growth disorders with the CrescNet system at the Leipzig treatment center.

Authors:  Wolfgang Hoepffner; Roland Pfäffle; Ruth Gausche; Christof Meigen; Eberhard Keller
Journal:  Dtsch Arztebl Int       Date:  2011-02-25       Impact factor: 5.594

6.  Adult height after long term treatment with recombinant growth hormone for idiopathic isolated growth hormone deficiency: observational follow up study of the French population based registry.

Authors:  Jean-Claude Carel; Emmanuel Ecosse; Marc Nicolino; Maïté Tauber; Juliane Leger; Sylvie Cabrol; Irène Bastié-Sigeac; Jean-Louis Chaussain; Joël Coste
Journal:  BMJ       Date:  2002-07-13

Review 7.  Growth hormone therapy in childhood-onset growth hormone deficiency: adult anthropometric and psychological outcomes.

Authors:  D E Sandberg; M H MacGillivray
Journal:  Endocrine       Date:  2000-04       Impact factor: 3.925

8.  Monitoring Adherence Rate to Growth Hormone Therapy and Growth Outcomes in Taiwanese Children Using Easypod Connect: Observational Study.

Authors:  Pen-Hua Su; Chen Yang; Mei-Chyn Chao; Chung-Lin Chiang
Journal:  JMIR Pediatr Parent       Date:  2021-01-15

Review 9.  Short and Long-Term Effects of Growth Hormone in Children and Adolescents With GH Deficiency.

Authors:  Michael B Ranke
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-01       Impact factor: 5.555

10.  The first-year growth response to growth hormone treatment predicts the long-term prepubertal growth response in children.

Authors:  Berit Kriström; Jovanna Dahlgren; Aimon Niklasson; Andreas F M Nierop; Kerstin Albertsson-Wikland
Journal:  BMC Med Inform Decis Mak       Date:  2009-01-12       Impact factor: 2.796

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.